Skip to main content

Table 2 Mean difference (95%CI) of standardized NMR-metabolites per 1-point increase in HLS in the Hortega Studya

From: Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain

Ā Ā 

Model 1

Model 2

Group

Metabolite

MD (95% CI)

p-value

MD (95% CI)

p-value

Lipoprotein profile

Cholesterol, mmol/l

ā€ƒVLDL cholesterol

āˆ’0.07 (āˆ’ā€‰0.09, āˆ’ā€‰0.04)

<ā€‰0.001

āˆ’ā€‰0.05 (āˆ’ā€‰0.07, āˆ’ā€‰0.03)

<ā€‰0.001*

ā€ƒLDL cholesterol

āˆ’0.11 (āˆ’ā€‰0.17, āˆ’ā€‰0.05)

<ā€‰0.001

āˆ’0.03 (āˆ’ā€‰0.06, 0.002)

0.04

ā€ƒHDL cholesterol

0.04 (0.02, 0.07)

0.001

0.05 (0.02, 0.07)

<ā€‰0.001*

ā€ƒIDL cholesterol

āˆ’0.02 (āˆ’ā€‰0.03, āˆ’ā€‰0.01)

<ā€‰0.001

āˆ’0.01 (āˆ’ā€‰0.02, āˆ’ā€‰0.003)

0.006*

Triglycerides, mmol/l

ā€ƒVLDL triglycerides

āˆ’0.13 (āˆ’ā€‰0.19, āˆ’ā€‰0.08)

<ā€‰0.001

āˆ’0.1 (āˆ’ā€‰0.14, āˆ’ā€‰0.05)

<ā€‰0.001*

ā€ƒLDL triglycerides

āˆ’0.007 (āˆ’ā€‰0.01, āˆ’ā€‰0.002)

0.006

āˆ’0.001 (āˆ’ā€‰0.005, 0.002)

0.43

ā€ƒHDL triglycerides

āˆ’0.003 (āˆ’ā€‰0.01, 0.0007)

0.11

āˆ’0.002 (āˆ’ā€‰0.01, 0.002)

0.24

ā€ƒIDL triglycerides

āˆ’0.007 (āˆ’ā€‰0.01, āˆ’ā€‰0.04)

<ā€‰0.001

āˆ’0.005 (āˆ’ā€‰0.01, āˆ’ā€‰0.002)

0.003*

Lipoprotein particle concentration

ā€ƒLarge VLDL, nmol/L

āˆ’0.18 (āˆ’ā€‰0.27, āˆ’ā€‰0.09)

<ā€‰0.001

āˆ’0.13 (āˆ’ā€‰0.21, āˆ’ā€‰0.06)

<ā€‰0.001*

ā€ƒMedium VLDL, nmol/L

āˆ’1.13 (āˆ’ā€‰1.64, āˆ’ā€‰0.62)

<ā€‰0.001

āˆ’0.78 (āˆ’ā€‰1.24, āˆ’ā€‰0.33)

<ā€‰0.001*

ā€ƒSmall VLDL, nmol/L

āˆ’ā€‰7.34 (āˆ’ā€‰10.21, āˆ’ā€‰4.47)

<ā€‰0.001

āˆ’5.33 (āˆ’ā€‰7.85, āˆ’ā€‰2.80)

<ā€‰0.001*

ā€ƒLarge LDL, nmol/L

āˆ’4.58 (āˆ’ā€‰7.54, āˆ’ā€‰1.63)

0.002

āˆ’ā€‰0.98 (āˆ’ā€‰2.79, 0.83)

0.29

ā€ƒMedium LDL, nmol/L

āˆ’ā€‰10.11 (āˆ’ā€‰19.62, āˆ’ā€‰0.6)

0.04

1.19 (āˆ’ā€‰4.59, 6.97)

0.69

ā€ƒSmall LDL, nmol/L

āˆ’35.75 (āˆ’ā€‰50.87, āˆ’ā€‰20.63)

<ā€‰0.001

āˆ’19.43 (āˆ’ā€‰29.00, āˆ’ā€‰9.87)

<ā€‰0.001*

ā€ƒLarge HDL, Ī¼mol/L

0.001 (āˆ’ā€‰0.003, 0.01)

0.68

0.003 (0.0002, 0.01)

0.04

ā€ƒMedium HDL, Ī¼mol/L

0.22 (0.06, 0.38)

0.008

0.24 (0.08, 0.4)

0.003*

ā€ƒSmall HDL Ī¼mol/L

0.25 (āˆ’ā€‰0.08, 0.57)

0.13

0.35 (0.02, 0.67)

0.04

Amino acids b

Alanine

0.14 (0.08, 0.20)

<ā€‰0.001

0.11 (0.06, 0.17)

<ā€‰0.001*

Creatine phosphate

0.02 (0.01, 0.03)

<ā€‰0.001

0.01 (0.002, 0.02)

0.01*

Creatine

0.02 (0.01, 0.03)

<ā€‰0.001

0.01 (0.005, 0.02)

<ā€‰0.001*

Cysteine

0.02 (0.01, 0.02)

<ā€‰0.001

0.01 (0.004, 0.02)

0.002*

Glutamine

0.11 (0.07, 0.15)

<ā€‰0.001

0.08 (0.04, 0.12)

<ā€‰0.001*

N-acetylglutamine

0.08 (0.05, 0.11)

<ā€‰0.001

0.06 (0.03, 0.08)

<ā€‰0.001*

Proline

0.12 (0.07, 0.16)

<ā€‰0.001

0.09 (0.05, 0.12)

<ā€‰0.001*

Tryptophan

0.03 (0.01, 0.06)

0.02

0.02 (0, 0.05)

0.06

Tyrosine

0.02 (0.01, 0.04)

0.002

0.01 (0, 0.02)

0.08

Isoleucine

0.05 (0.02, 0.08)

0.003

0.04 (0, 0.07)

0.02

Leucine

0.05 (0.02, 0.08)

<ā€‰0.001

0.04 (0.01, 0.07)

0.01*

Valine

0.05 (0.02, 0.09)

0.003

0.04 (0.01, 0.08)

0.02

Fatty acids b

CH2CH2CO

āˆ’0.19 (āˆ’0.29, āˆ’0.09)

<ā€‰0.001

āˆ’0.14 (āˆ’ā€‰0.24, āˆ’ā€‰0.04)

0.006*

CH2CH3

āˆ’ā€‰0.13 (āˆ’ā€‰0.24, āˆ’ā€‰0.03)

0.009

āˆ’ā€‰0.07 (āˆ’ā€‰0.17, 0.03)

0.15

CH2N

āˆ’3.17 (āˆ’4.44, āˆ’1.89)

<ā€‰0.001

āˆ’2.17 (āˆ’3.33, āˆ’1.00)

<ā€‰0.001*

CH3

āˆ’0.38 (āˆ’ā€‰0.61, āˆ’ā€‰0.15)

0.001

āˆ’0.19 (āˆ’ā€‰0.37, āˆ’ā€‰0.003)

0.05

CHCH2CH

āˆ’ā€‰0.03 (āˆ’ā€‰0.08, 0.03)

0.33

āˆ’0.003 (āˆ’ā€‰0.05, 0.05)

0.92

Isobutyrate

0.04 (0.01, 0.07)

0.003

0.03 (0.01, 0.06)

0.01*

Fluid balance b

Albumin

0.11 (0.07, 0.16)

<ā€‰0.001

0.07 (0.03, 0.11)

<ā€‰0.001*

Creatinine

0.03 (0.01, 0.04)

<ā€‰0.001

0.02 (0.01, 0.03)

<ā€‰0.001*

Energy metabolism b

Glycolysis

ā€ƒCitrate

0.07 (0.04, 0.09)

<ā€‰0.001

0.05 (0.03, 0.07)

<ā€‰0.001*

ā€ƒLactate

āˆ’0.34 (āˆ’0.6, āˆ’ā€‰0.09)

0.009

āˆ’ā€‰0.24 (āˆ’ā€‰0.48, 0.01)

0.06

ā€ƒPyruvate

0.03 (0.02, 0.04)

<ā€‰0.001

0.02 (0.01, 0.03)

<ā€‰0.001*

Ketone bodies

ā€ƒAcetate

0.05 (0.03, 0.07)

<ā€‰0.001

0.03 (0.01, 0.05)

0.001*

ā€ƒAcetone

āˆ’0.13 (āˆ’ā€‰0.19, āˆ’ā€‰0.08)

<ā€‰0.001

āˆ’0.10 (āˆ’ā€‰0.16, āˆ’ā€‰0.05)

<ā€‰0.001*

ā€ƒ3-Hydroxybutyrate

0.11 (0.07, 0.15)

<ā€‰0.001

0.08 (0.04, 0.12)

<ā€‰0.001*

Products of bacterial co-metabolism b

Ethanol

āˆ’0.05 (āˆ’ā€‰0.16, 0.06)

0.39

āˆ’0.06 (āˆ’ā€‰0.16, 0.04)

0.24

Isopropanol

0.08 (0.05, 0.11)

<ā€‰0.001

0.05 (0.03, 0.08)

<ā€‰0.001*

Methanol

0.01 (0.002, 0.02)

0.008

0.01 (āˆ’0.0001, 0.01)

0.05

Trimethylamines

0.09 (0.05, 0.12)

<ā€‰0.001

0.06 (0.03, 0.09)

<ā€‰0.001*

Phenylpropionate

0.11 (0.07, 0.16)

<ā€‰0.001

0.09 (0.05, 0.14)

<ā€‰0.001*

Phosphoethanolamines b

O-phosphoethanolamine

0.07 (0.04, 0.10)

<ā€‰0.001

0.04 (0.02, 0.07)

0.002*

  1. Abbreviations: MD mean differences; CI confidence interval; HLS Healthy Lifestyle Score. a nā€‰=ā€‰1016
  2. Model 1 was adjusted for age (years), sex (men, women) and education (ā‰¤ high school, > high school). Model 2 was model 1 additionally adjusted for prevalent hypertension (no, yes), total plasma cholesterol (mg/dL) and use of lipid lowering medication (no, yes)
  3. b We normalized the spectral vector to the total spectral area excluding residual water signals to minimize the effects of variable dilution of the sample. The metabolic content is therefore expressed in relative metabolic content (unitless)
  4. * Significant at a 2.5% False Discovery Rate